AR and prostate carcinoma: To overcame hormonal responses in prostate cancer, Yang et al. [60] developed a biodegradable poly-dl-lactic-co-glycolic acid polymer-based nanoparticle able of encapsulating an androgen receptor (AR) shRNA construct.